# | Title | Journal | Year | Citations |
---|
1 | Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients | Biomarker Insights | 2016 | 620 |
2 | Reactive Oxygen Species: A Key Constituent in Cancer Survival | Biomarker Insights | 2018 | 590 |
3 | Immunohistochemistry as an Important Tool in Biomarkers Detection and Clinical Practice | Biomarker Insights | 2010 | 295 |
4 | Prognostic Values of microRNAs in Colorectal Cancer | Biomarker Insights | 2006 | 223 |
5 | A list of candidate cancer biomarkers for targeted proteomics | Biomarker Insights | 2007 | 222 |
6 | MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data | Biomarker Insights | 2015 | 154 |
7 | Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis | Biomarker Insights | 2009 | 145 |
8 | Human Chitinases and Chitinase-Like Proteins as Indicators for Inflammation and Cancer | Biomarker Insights | 2007 | 141 |
9 | Validation of a Blood-Based Laboratory Test to Aid in the Confirmation of a Diagnosis of Schizophrenia | Biomarker Insights | 2010 | 137 |
10 | Molecular Serum Markers of Liver Fibrosis | Biomarker Insights | 2012 | 132 |
11 | Making Meaningful Clinical Use of Biomarkers | Biomarker Insights | 2017 | 125 |
12 | Prednisolone-Induced Predisposition to Femoral Head Separation and the Accompanying Plasma Protein Changes in Chickens | Biomarker Insights | 2015 | 123 |
13 | Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial | Biomarker Insights | 2015 | 109 |
14 | Biological Functions of the Genes in the Mammaprint Breast Cancer Profile Reflect the Hallmarks of Cancer | Biomarker Insights | 2010 | 103 |
15 | Quantification of Plasma miRNAs by Digital PCR for Cancer Diagnosis | Biomarker Insights | 2013 | 103 |
16 | Biomarkers for Sepsis: What is and What Might Be? | Biomarker Insights | 2015 | 94 |
17 | Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases | Biomarker Insights | 2018 | 92 |
18 | Oncogenic Roles and Inhibitors of DNMT1, DNMT3A, and DNMT3B in Acute Myeloid Leukaemia | Biomarker Insights | 2019 | 87 |
19 | Human chitinases and chitinase-like proteins as indicators for inflammation and cancer | Biomarker Insights | 2007 | 83 |
20 | Serological Investigation of the Collagen Degradation Profile of Patients with Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis | Biomarker Insights | 2012 | 79 |
21 | Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells Using Monolayer Culture | Biomarker Insights | 2015 | 76 |
22 | Sample Stability and Protein Composition of Saliva: Implications for Its Use as a Diagnostic Fluid | Biomarker Insights | 2008 | 75 |
23 | Heart Rate Variability as a Biomarker for Predicting Stroke, Post-stroke Complications and Functionality | Biomarker Insights | 2018 | 75 |
24 | Genomic, Proteomic, and Metabolomic Data Integration Strategies | Biomarker Insights | 2015 | 74 |
25 | Fluid Biomarkers for Synaptic Dysfunction and Loss | Biomarker Insights | 2020 | 74 |
26 | Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy | Biomarker Insights | 2009 | 72 |
27 | A List of Candidate Cancer Biomarkers for Targeted Proteomics | Biomarker Insights | 2006 | 69 |
28 | Methodology and Applications of Disease Biomarker Identification in Human Serum | Biomarker Insights | 2007 | 65 |
29 | Assessment of mRNA and microRNA Stabilization in Peripheral Human Blood for Multicenter Studies and Biobanks | Biomarker Insights | 2010 | 65 |
30 | Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population | Biomarker Insights | 2014 | 64 |
31 | Analysis of Copper and Zinc Plasma Concentration and the Efficacy of Zinc Therapy in Individuals with Asperger's Syndrome, Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and Autism | Biomarker Insights | 2011 | 62 |
32 | Novel Biomarkers for the Diagnosis of Urinary Tract Infection–-A systematic Review | Biomarker Insights | 2009 | 60 |
33 | Detection of Homocysteine and C-Reactive Protein in the Saliva of Healthy Adults: Comparison with Blood Levels | Biomarker Insights | 2010 | 60 |
34 | Pulmonary Biomarkers of Bronchopulmonary Dysplasia | Biomarker Insights | 2008 | 56 |
35 | Protein Modifications as Potential Biomarkers in Breast Cancer | Biomarker Insights | 2009 | 54 |
36 | Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury | Biomarker Insights | 2012 | 53 |
37 | Low Doses of Cisplatin Induce Gene Alterations, Cell Cycle Arrest, and Apoptosis in Human Promyelocytic Leukemia Cells | Biomarker Insights | 2016 | 52 |
38 | Biomarkers of Ovarian Reserve | Biomarker Insights | 2008 | 51 |
39 | Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Diabetic Patients with Nephropathy | Biomarker Insights | 2016 | 51 |
40 | Biomarkers of Dose and Effect of Inhaled Ozone in Resting versus Exercising Human Subjects: Comparison with Resting Rats | Biomarker Insights | 2013 | 49 |
41 | Biomarkers of Adiponectin: Plasma Protein Variation and Genomic DNA Polymorphisms | Biomarker Insights | 2009 | 48 |
42 | Urinary Vitamin D-Binding Protein as a Biomarker of Steroid-Resistant Nephrotic Syndrome | Biomarker Insights | 2016 | 48 |
43 | Measurement of CO3-610, a Potential Liver Biomarker Derived from Matrix Metalloproteinase-9 Degradation of Collagen Type III, in a Rat Model of Reversible Carbon-Tetrachloride-Induced Fibrosis | Biomarker Insights | 2011 | 46 |
44 | Validation of Candidate Serum Ovarian Cancer Biomarkers for Early Detection | Biomarker Insights | 2007 | 45 |
45 | H HRMAS NMR Derived Bio-markers Related to Tumor Grade, Tumor Cell Fraction, and Cell Proliferation in Prostate Tissue Samples | Biomarker Insights | 2011 | 45 |
46 | Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape | Biomarker Insights | 2020 | 44 |
47 | FTIR Microspectroscopy Coupled with Two-Class Discrimination Segregates Markers Responsible for Inter- and Intra-Category Variance in Exfoliative Cervical Cytology | Biomarker Insights | 2008 | 42 |
48 | The Roles of Neuregulin-1 in Cardiac Development, Homeostasis, and Disease | Biomarker Insights | 2015 | 42 |
49 | DNA methylation in circulating tumour DNA as a biomarker for cancer | Biomarker Insights | 2008 | 42 |
50 | Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels | Biomarker Insights | 2011 | 41 |